Showing results (1451-1460 of 1,573) with videos related to

Sort By:
Pageof 158
Experimental & Molecular Medicine|September 1, 2024
Emerin mislocalization during chromatin bridge resolution can drive prostate cancer cell invasiveness in a collagen-rich microenvironmentMarta Popęda, Kamil Kowalski, Tomasz Wenta, et al.
Annals of Hematology|May 17, 2023
Therapy results in pediatric Hodgkin lymphoma - does less mean better? Experience from a single children's oncology centerJoanna Stankiewicz, Andrzej Kołtan, Ewa Demidowicz, et al.
Neurology|May 22, 1998
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, N A Simonian, J A Alam, et al.
Emerging Microbes & Infections|November 19, 2024
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trialSimon Valayer, Marie Alexandre, Mélanie Prague, et al.
Cell and Tissue Banking|July 17, 2004
The establishment of a network of European human research tissue banksSamantha Orr, Eliane Alexandre, Brain Clark, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 23, 2008
Differential diagnosis of suspected multiple sclerosis: a consensus approachD H Miller, B G Weinshenker, M Filippi, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2023
Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant CandidatesShanti Balasubramanian, Mary E Richert, Hyesik Kong, et al.
Plos Medicine|January 11, 2022
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trialZacchaeus Anywaine, Houreratou Barry, Omu Anzala, et al.
Plos Medicine|October 29, 2021
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in AfricaHoureratou Barry, Gaudensia Mutua, Hannah Kibuuka, et al.
Neurology|July 17, 1999
A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)J H Simon, L D Jacobs, M K Campion, et al.
Pageof 158